Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival.

MLA

Zhang, Wu, et al. “Inactivation of PBX3 and HOXA9 by Down-Regulating H3K79 Methylation Represses NPM1-Mutated Leukemic Cell Survival.” Theranostics, vol. 8, no. 16, July 2018, pp. 4359–71. EBSCOhost, https://doi.org/10.7150/thno.26900.

APA

Zhang, W., Zhao, C., Zhao, J., Zhu, Y., Weng, X., Chen, Q., Sun, H., Mi, J.-Q., Li, J., Zhu, J., Chen, Z., Pandolfi, P. P., Chen, S., Yan, X., & Xu, J. (2018). Inactivation of PBX3 and HOXA9 by down-regulating H3K79 methylation represses NPM1-mutated leukemic cell survival. Theranostics, 8(16), 4359–4371. https://doi.org/10.7150/thno.26900

Chicago

Zhang, Wu, Chen Zhao, Junmei Zhao, Yongmei Zhu, Xiangqin Weng, Qiusheng Chen, Huiping Sun, et al. 2018. “Inactivation of PBX3 and HOXA9 by Down-Regulating H3K79 Methylation Represses NPM1-Mutated Leukemic Cell Survival.” Theranostics 8 (16): 4359–71. doi:10.7150/thno.26900.